Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke
Authors:
- 21 August 2014
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (11) , 11677-11683
Abstract
Collagen triple helix repeat containing 1 (Cthrc1) has been recently documented in various malignancies, but its role in non-small cell lung cancer (NSCLC) remains uncertain. In the current study, we investigated the level of Cthrc1 in NSCLC tissues by immunohistochemistry. Results revealed that Cthrc1 overexpression was significantly associated with differentiation (P = 0.039), tumor–node–metastasis (TNM) stage (P = 0.035), lymph node status (P = 0.001), and cigarette smoke (P = 0.037). Furthermore, it was shown that patients with high Cthrc1 expression had significantly poorer overall survival (OS) and disease-free survival (DFS; P = 0.004 and P = 0.010, respectively). Interestingly, high Cthrc1 expression was an independent prognostic factor for both OS and DFS (P = 0.010 and P = 0.005, respectively) only in NSCLCs with cigarette smoke. These results indicated and suggested that Cthrc1 could be used as a prognostic marker for NSCLC, and it may play an important role in the smoked-related NSCLC.Keywords
This publication has 26 references indexed in Scilit:
- Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motilityInternational Journal of Oncology, 2014
- Collagen Triple Helix Repeat Containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cellsOncotarget, 2014
- Differential Expression and Prognostic Role of Selected Genes in Colorectal Cancer Patients2013
- Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor PrognosisPLOS ONE, 2013
- Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Invasive Ductal Carcinoma of the Breast: The Impact on Prognosis and Correlation to Clinicopathologic FeaturesPathology and Oncology Research, 2013
- Germline Mutations in MSR1, ASCC1, and CTHRC1 in Patients With Barrett Esophagus and Esophageal AdenocarcinomaJAMA, 2011
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Non–Small-Cell Lung Cancer Vaccine Therapy: A Concise ReviewJournal of Clinical Oncology, 2005
- Collagen Triple Helix Repeat Containing 1, a Novel Secreted Protein in Injured and Diseased Arteries, Inhibits Collagen Expression and Promotes Cell MigrationCirculation Research, 2005
- APPRAISAL OF THE WORLD-HEALTH-ORGANIZATION CLASSIFICATION OF LUNG-TUMORS1980